368 related articles for article (PubMed ID: 10079107)
1. Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.
Murphy B; Magee CC; Alexander SI; Waaga AM; Snoeck HW; Vella JP; Carpenter CB; Sayegh MH
J Clin Invest; 1999 Mar; 103(6):859-67. PubMed ID: 10079107
[TBL] [Abstract][Full Text] [Related]
2. Peptide-mediated immunosuppression.
Zang W; Murphy B
Am J Ther; 2005; 12(6):592-9. PubMed ID: 16280653
[TBL] [Abstract][Full Text] [Related]
3. The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination.
Kovalik JP; Singh N; Mendiratta SK; Martin WD; Ignatowicz L; Van Kaer L
J Immunol; 2000 Aug; 165(3):1285-93. PubMed ID: 10903728
[TBL] [Abstract][Full Text] [Related]
4. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
[TBL] [Abstract][Full Text] [Related]
5. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
[TBL] [Abstract][Full Text] [Related]
6. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
7. A novel mechanism for the immunomodulatory functions of class II MHC-derived peptides.
Murphy B; Yu J; Jiao Q; Lin M; Chitnis T; Sayegh MH
J Am Soc Nephrol; 2003 Apr; 14(4):1053-65. PubMed ID: 12660341
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
10. Luminal bacterial antigen-specific CD4+ T-cell responses in HLA-B27 transgenic rats with chronic colitis are mediated by both major histocompatibility class II and HLA-B27 molecules.
Qian BF; Tonkonogy SL; Balfour Sartor R
Immunology; 2006 Mar; 117(3):319-28. PubMed ID: 16476051
[TBL] [Abstract][Full Text] [Related]
11. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.
Majlessi L; Bordenave G
Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483
[TBL] [Abstract][Full Text] [Related]
12. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
Asnagli H; Schmitt-Verhulst AM; Guimezanes A
J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
[TBL] [Abstract][Full Text] [Related]
13. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells.
Kobayashi H; Kimura S; Aoki N; Sato K; Celis E; Katagiri M
Immunogenetics; 2001 Oct; 53(8):626-33. PubMed ID: 11797095
[TBL] [Abstract][Full Text] [Related]
14. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate.
Zhao Y; Scott NA; Quah HS; Krishnamurthy B; Bond F; Loudovaris T; Mannering SI; Kay TW; Thomas HE
Eur J Immunol; 2015 Sep; 45(9):2494-503. PubMed ID: 25959978
[TBL] [Abstract][Full Text] [Related]
15. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
16. Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion?
Tsang JY; Chai JG; Lechler R
Blood; 2003 Apr; 101(7):2704-10. PubMed ID: 12433692
[TBL] [Abstract][Full Text] [Related]
17. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
Agrawal B; Manickasundari M; Fraga E; Singh B
J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
[TBL] [Abstract][Full Text] [Related]
18. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
19. Selective antigen presenting activity of cortical thymic epithelial cells against CD4+ T cells associated with both lack of costimulatory molecules and inefficient presentation of MHC-peptide ligands.
Kaneda R; Iwabuchi K; Kasai M; Murakami M; Uede T; Onoé K
Cell Immunol; 1997 Nov; 181(2):163-71. PubMed ID: 9398403
[TBL] [Abstract][Full Text] [Related]
20. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
